News items Radboudumc and KNAW join the Netherlands Centre for One Health
11 January 2018

Radboud University Medical Center (Radboudumc) and the Royal Netherlands Academy of Arts and Sciences (KNAW) have joined the Netherlands Centre for One Health (NCOH) as Partner as per 1 January 2018. NCOH unites experts from Utrecht University, University Medical Center Utrecht, Wageningen University and Research, Erasmus Medical Center Rotterdam, Academic Medical Center Amsterdam, Leiden University, and Leiden University Medical Center in the areas of human and animal health, thereby forming a strong academic network on infectious diseases in the Netherlands.

Infectious diseases have an increasingly large impact on the health of humans and animals worldwide, including densely-populated countries like the Netherlands. In 2050, about ten million people are predicted to die worldwide from antibiotic-resistant bacterial infections alone if we do not find new solutions, while viral infections are also spreading at an alarming rate. The four NCOH strategic research themes  focus on studying the interactions and connections between human, veterinary, wildlife, and environmental health in pursuit of durable solutions to the grand societal challenges requiring a One Health approach.

“To find new solutions to combat infectious diseases, like the issue of antimicrobial resistance, we need a holistic view and a multidisciplinary approach, which is an important reason for us to join NCOH”, says professor Heiman Wertheim, clinical microbiologist and chair of the Radboud Center of Infectious Diseases. “At Radboudumc we have a strong research theme on infectious diseases and global health with operational multidisciplinary research networks worldwide. Recently we recruited a PhD student as part of the NCOH collaboration who will work on fungal infections where antimicrobial resistance is a major, but often neglected, issue. We look forward to contribute to NCHOH, learn from each other and conduct relevant research together.”

The Royal Netherlands Academy of Arts and Sciences (KNAW) will participate in NCOH through three of its institutes that are thematically linked to the NCOH Strategic Research Agenda: Westerdijk Fungal Biodiversity Institute, Hubrecht Institute for Developmental Biology & Stem Cell Research, and Netherlands Institute of Ecology (NIOO).

“With Radboudumc and the KNAW both joining the NCOH as a partner, the leading academic research institutes will now form an even stronger academic network on infectious diseases in the Netherlands. NCOH is indeed a joint scientific force further tackling One Health issues in public health, animal health, food production and the environment, with an integrated and interdisciplinary approach”, says Martin Scholten, chairman of the NCOH Supervisory Board.

More information about NCOH

Solutions to Global One Health Challenges. The Netherlands Centre for One Health (NCOH) bundles top-leading academic research institutes in the Netherlands in an open innovation network focused on One Health: public, veterinary, wildlife, and ecosystems health. It aims for an integrated approach to face the global risk of infectious diseases and to develop durable solutions regarding grand societal health challenges. This virtual science-driven institution focuses its research and increase of knowledge on antibiotic resistance, emerging infectious diseases, smart farming, and healthy ecosystems. The NCOH stimulates collaboration between academic and research institutes, governments, NGOs, public health institutes, and industrial partners. The NCOH partners are Academic Medical Center Amsterdam, Erasmus Medical Center Rotterdam, Leiden University, Leiden University Medical Center, Radboud University Medical Center, Royal Netherlands Academy of Arts and Sciences (KNAW), University Medical Center Utrecht, Utrecht University, and Wageningen University and Research.

Related news items


Antibodies are sustained in nasal fluid after mild corona infection

27 September 2021 Testing through nasal fluids is easier than through blood read more

First volunteers vaccinated with Radboudumc malaria vaccine

20 May 2021 Today a new vaccine against malaria, largely developed in Nijmegen, is being tested for the first time in volunteers at Radboudumc. read more

Invasive fungal infections in influenza and COVID-19

8 July 2020 The Aspergillus fungus is found in the lungs of many COVID patients. A parallel occurs with influenza patients, who often develop a serious fungal infection. Although such a serious fungal infection seems to occur less frequently in COVID-patients, alertness remains necessary, read more

Radboudumc researchers publish new insights into COVID-19 Consequences for treatment are now being examined internationally

10 April 2020 Researchers at the Radboud university medical center seem to have found an essential mechanism in the disease process of Covid-19, which has so far been overlooked. If the insight is correct, it probably has important consequences for the treatment of the disease. read more

Veterinary drug can prevent outbreaks of malaria and Zika in humans

5 July 2018 Drugs that protect pets against ticks and fleas can also be used to prevent outbreaks of malaria, Zika and dengue fever in humans. This was the conclusion of an article by scientists from TropIQ Health Sciences, together with English and American colleagues, and published in the journal PNAS. read more